The Economic Times daily newspaper is available online now.

    Buy Eris Lifesciences, target price Rs 780: Motilal Oswal Financial Services

    Synopsis

    Eris Lifesciences, incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 8701.37 Crore) operating in Pharmaceuticals sector.

    ErisAgencies
    The company has built multiple levers for growth in branded generics space
    Motilal Oswal Financial Services has buy call on Eris Lifesciences with a target price of Rs 780. The current market price of Eris Lifesciences is Rs 640.85.

    Eris Lifesciences, incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 8701.37 Crore) operating in Pharmaceuticals sector.

    Eris Lifesciences key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2022.

    Financials
    For the quarter ended 31-12-2022, the company has reported a Consolidated Total Income of Rs 425.50 Crore, down -8.63 % from last quarter Total Income of Rs 465.68 Crore and up 26.13 % from last year same quarter Total Income of Rs 337.34 Crore. Company has reported net profit after tax of Rs 100.23 Crore in latest quarter.

    The company’s top management includes Mr.Amit Bakshi, Mr.Krishnakumar Vaidyanathan, Mr.Inderjeet Singh Negi, Mr.Kaushal Shah, Mr.Rajeev Dalal, Mr.Vasudevan Sujesh, Ms.Kalpana Unadkat, Mr.Prashant Gupta. Company has Deloitte Haskins & Sells LLP as its auditors. As on 30-09-2022, the company has a total of 14 Crore shares outstanding.

    Investment Rationale
    The company has built multiple levers for growth in branded generics space by a)broadening dermatology portfolio through acquisitions, b) adding Insulin and its analogues in the anti-diabetes segment, c) sustained uptick inDPP4/SGLT2 sales, leveraging patient care platform and specialist engagement, and d) adding MRs to increase reach. Considering these factors and attractive valuations, the brokerage reiterate its BUY rating on the stock.

    Promoter/FII Holdings
    Promoters held 52.29 per cent stake in the company as of 30-Sep-2022, while FIIs owned 15.35 per cent, DIIs 10.69 per cent.



    (Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
    (What's moving Sensex and Nifty Track latest market news, stock tips and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.

    Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

    ...more


    (What's moving Sensex and Nifty Track latest market news, stock tips and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.

    Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

    ...more
    The Economic Times

    Stories you might be interested in